|
LSS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.77748959784685E-12 |
| Normal-vs-Stage2 |
3.57189999800056E-09 |
| Normal-vs-Stage3 |
5.55111512312578E-16 |
| Normal-vs-Stage4 |
1.63913327355658E-12 |
| Stage1-vs-Stage2 |
1.398840E-01 |
| Stage1-vs-Stage3 |
8.039800E-03 |
| Stage1-vs-Stage4 |
3.662300E-03 |
| Stage2-vs-Stage3 |
6.695200E-01 |
| Stage2-vs-Stage4 |
4.212800E-01 |
| Stage3-vs-Stage4 |
6.092000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.838600E-03 |
| Normal-vs-Asian |
2.619600E-02 |
| Caucasian-vs-AfricanAmerican |
8.041800E-03 |
| Caucasian-vs-Asian |
2.587200E-01 |
| AfricanAmerican-vs-Asian |
8.098600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
8.03380029168466E-10 |
| Male-vs-Female |
1.179880E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.377200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.66233693477125E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
8.71319999484754E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.866200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.184200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.761000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.426600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.302600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.670000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.402200E-01 |
| Normal-vs-Grade 2 |
3.88578058618805E-15 |
| Normal-vs-Grade 3 |
9.99200722162641E-16 |
| Normal-vs-Grade 4 |
1.62492241884138E-12 |
| Grade 1-vs-Grade 2 |
4.411700E-04 |
| Grade 1-vs-Grade 3 |
9.987600E-04 |
| Grade 1-vs-Grade 4 |
4.22690000000392E-05 |
| Grade 2-vs-Grade 3 |
3.542600E-01 |
| Grade 2-vs-Grade 4 |
1.011790E-02 |
| Grade 3-vs-Grade 4 |
1.095630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63646873829748E-12 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
6.878300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62458935193399E-12 |
| Normal-vs-N1 |
4.05410000015038E-08 |
| N0-vs-N1 |
4.876000E-01 |
|
|
